[HTML][HTML] Serial procalcitonin predicts mortality in severe sepsis patients: results from the multicenter procalcitonin MOnitoring SEpsis (MOSES) study
P Schuetz, R Birkhahn, R Sherwin, AE Jones… - Critical care …, 2017 - journals.lww.com
Objectives: To prospectively validate that the inability to decrease procalcitonin levels by
more than 80% between baseline and day 4 is associated with increased 28-day all-cause …
more than 80% between baseline and day 4 is associated with increased 28-day all-cause …
Serial Procalcitonin Predicts Mortality in Severe Sepsis Patients: Results From the Multicenter Procalcitonin MOnitoring SEpsis (MOSES) Study
P Schuetz, R Birkhahn, R Sherwin, AE Jones… - Critical Care …, 2017 - cir.nii.ac.jp
抄録< jats: sec>< jats: title> Objectives:</jats: title>< jats: p> To prospectively validate that the
inability to decrease procalcitonin levels by more than 80% between baseline and day 4 is …
inability to decrease procalcitonin levels by more than 80% between baseline and day 4 is …
Serial procalcitonin predicts mortality in severe sepsis patients: Results from the multicenter procalcitonin monitoring SEpsis (MOSES) Study
P Schuetz, R Birkhahn, R Sherwin… - Critical care …, 2017 - utsouthwestern.elsevierpure.com
Objectives: To prospectively validate that the inability to decrease procalcitonin levels by
more than 80% between baseline and day 4 is associated with increased 28-day all-cause …
more than 80% between baseline and day 4 is associated with increased 28-day all-cause …
Serial Procalcitonin Predicts Mortality in Severe Sepsis Patients: Results From the Multicenter Procalcitonin MOnitoring SEpsis (MOSES) Study.
P Schuetz, R Birkhahn, R Sherwin, AE Jones… - Critical Care …, 2017 - europepmc.org
Serial Procalcitonin Predicts Mortality in Severe Sepsis Patients: Results From the Multicenter
Procalcitonin MOnitoring SEpsis (MOSES) Study. - Abstract - Europe PMC Sign in | Create an …
Procalcitonin MOnitoring SEpsis (MOSES) Study. - Abstract - Europe PMC Sign in | Create an …
Serial Procalcitonin Predicts Mortality in Severe Sepsis Patients: Results From the Multicenter Procalcitonin MOnitoring SEpsis (MOSES) Study.
P Schuetz, R Birkhahn… - Critical care …, 2017 - scholarlycommons.henryford.com
OBJECTIVES: To prospectively validate that the inability to decrease procalcitonin levels by
more than 80% between baseline and day 4 is associated with increased 28-day all-cause …
more than 80% between baseline and day 4 is associated with increased 28-day all-cause …
Serial procalcitonin predicts mortality in severe sepsis patients: Results from the multicenter procalcitonin monitoring SEpsis (MOSES) Study
P Schuetz, R Birkhahn, R Sherwin… - Critical care …, 2017 - scholars.northwestern.edu
Objectives: To prospectively validate that the inability to decrease procalcitonin levels by
more than 80% between baseline and day 4 is associated with increased 28-day all-cause …
more than 80% between baseline and day 4 is associated with increased 28-day all-cause …
Serial Procalcitonin Predicts Mortality in Severe Sepsis Patients: Results From the Multicenter Procalcitonin MOnitoring SEpsis (MOSES) Study.
P Schuetz, R Birkhahn, R Sherwin, AE Jones… - Critical care …, 2017 - folia.unifr.ch
MEASUREMENTS AND MAIN RESULTS The primary analysis of interest was the
relationship between a procalcitonin decrease of more than 80% from baseline to day 4 and …
relationship between a procalcitonin decrease of more than 80% from baseline to day 4 and …
Serial Procalcitonin Predicts Mortality in Severe Sepsis Patients: Results From the Multicenter Procalcitonin MOnitoring SEpsis (MOSES) Study
P Schuetz, R Birkhahn, R Sherwin… - Critical Care …, 2017 - ingentaconnect.com
Objectives: To prospectively validate that the inability to decrease procalcitonin levels by
more than 80% between baseline and day 4 is associated with increased 28-day all-cause …
more than 80% between baseline and day 4 is associated with increased 28-day all-cause …
[PDF][PDF] Serial Procalcitonin Predicts Mortality in Severe Sepsis Patients: Results From the Multicenter Procalcitonin MOnitoring SEpsis (MOSES) Study
J Center, NY Brook - 2017 - ubccriticalcaremedicine.ca
Objectives: To prospectively validate that the inability to decrease procalcitonin levels by
more than 80% between baseline and day 4 is associated with increased 28-day all-cause …
more than 80% between baseline and day 4 is associated with increased 28-day all-cause …
Serial procalcitonin predicts mortality in severe sepsis patients: results from the multicenter procalcitonin MOnitoring SEpsis (MOSES) study.
P Schuetz, R Birkhahn, R Sherwin, AE Jones, A Singer… - 2017 - cabidigitallibrary.org
Objectives: To prospectively validate that the inability to decrease procalcitonin levels by
more than 80% between baseline and day 4 is associated with increased 28-day all-cause …
more than 80% between baseline and day 4 is associated with increased 28-day all-cause …